A detailed history of Empowered Funds, LLC transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Empowered Funds, LLC holds 128,070 shares of OVID stock, worth $96,052. This represents 0.01% of its overall portfolio holdings.

Number of Shares
128,070
Previous 128,070 -0.0%
Holding current value
$96,052
Previous $390,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$2.72 - $4.04 $55,134 - $81,890
20,270 Added 18.8%
128,070 $390,000
Q3 2023

Nov 01, 2023

BUY
$3.23 - $3.97 $28,579 - $35,126
8,848 Added 8.94%
107,800 $413,000
Q2 2023

Jul 27, 2023

BUY
$2.53 - $3.89 $250,348 - $384,923
98,952 New
98,952 $324,000

Others Institutions Holding OVID

About Ovid Therapeutics Inc.


  • Ticker OVID
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,419,400
  • Market Cap $52.8M
  • Description
  • Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...
More about OVID
Track This Portfolio

Track Empowered Funds, LLC Portfolio

Follow Empowered Funds, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empowered Funds, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empowered Funds, LLC with notifications on news.